The E3 Ubiquitin Ligase Peli1 Deficiency Promotes Atherosclerosis Progression
Background: Atherosclerosis is a chronic inflammatory vascular disease and the main cause of death and morbidity. Emerging evidence suggests that ubiquitination plays an important role in the pathogenesis of atherosclerosis including control of vascular inflammation, vascular smooth muscle cell (VSM...
Saved in:
Published in | Cells (Basel, Switzerland) Vol. 11; no. 13; p. 2014 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Basel
MDPI AG
23.06.2022
MDPI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background: Atherosclerosis is a chronic inflammatory vascular disease and the main cause of death and morbidity. Emerging evidence suggests that ubiquitination plays an important role in the pathogenesis of atherosclerosis including control of vascular inflammation, vascular smooth muscle cell (VSMC) function and atherosclerotic plaque stability. Peli1 a type of E3 ubiquitin ligase has emerged as a critical regulator of innate and adaptive immunity, however, its role in atherosclerosis remains to be elucidated. Methods: Apoe−/− mice and Peli1-deficient Apoe−/− Peli1−/− mice were subject to high cholesterol diet. Post sacrifice, serum was collected, and atherosclerotic plaque size and parameters of atherosclerotic plaque stability were evaluated. Immunoprofiling and foam cell quantification were performed. Results: Peli1 deficiency does not affect atherosclerosis lesion burden and cholesterol levels, but promotes VSMCs foam cells formation, necrotic core expansion, collagen, and fibrous cap reduction. Apoe−/− Peli1−/− mice exhibit a storm of inflammatory cytokines, expansion of Th1, Th1, Th17, and Tfh cells, a decrease in regulatory T and B cells and induction of pro-atherogenic serum level of IgG2a and IgE. Conclusions: In the present study, we uncover a crucial role for Peli1 in atherosclerosis as an important regulator of inflammation and VSMCs phenotypic modulation and subsequently atherosclerotic plaque destabilization. |
---|---|
AbstractList | Background: Atherosclerosis is a chronic inflammatory vascular disease and the main cause of death and morbidity. Emerging evidence suggests that ubiquitination plays an important role in the pathogenesis of atherosclerosis including control of vascular inflammation, vascular smooth muscle cell (VSMC) function and atherosclerotic plaque stability. Peli1 a type of E3 ubiquitin ligase has emerged as a critical regulator of innate and adaptive immunity, however, its role in atherosclerosis remains to be elucidated. Methods: Apoe
−/−
mice and Peli1-deficient Apoe
−/−
Peli1
−/−
mice were subject to high cholesterol diet. Post sacrifice, serum was collected, and atherosclerotic plaque size and parameters of atherosclerotic plaque stability were evaluated. Immunoprofiling and foam cell quantification were performed. Results: Peli1 deficiency does not affect atherosclerosis lesion burden and cholesterol levels, but promotes VSMCs foam cells formation, necrotic core expansion, collagen, and fibrous cap reduction. Apoe
−/−
Peli1
−/−
mice exhibit a storm of inflammatory cytokines, expansion of Th1, Th1, Th17, and Tfh cells, a decrease in regulatory T and B cells and induction of pro-atherogenic serum level of IgG2a and IgE. Conclusions: In the present study, we uncover a crucial role for Peli1 in atherosclerosis as an important regulator of inflammation and VSMCs phenotypic modulation and subsequently atherosclerotic plaque destabilization. Background: Atherosclerosis is a chronic inflammatory vascular disease and the main cause of death and morbidity. Emerging evidence suggests that ubiquitination plays an important role in the pathogenesis of atherosclerosis including control of vascular inflammation, vascular smooth muscle cell (VSMC) function and atherosclerotic plaque stability. Peli1 a type of E3 ubiquitin ligase has emerged as a critical regulator of innate and adaptive immunity, however, its role in atherosclerosis remains to be elucidated. Methods: Apoe−/− mice and Peli1-deficient Apoe−/− Peli1−/− mice were subject to high cholesterol diet. Post sacrifice, serum was collected, and atherosclerotic plaque size and parameters of atherosclerotic plaque stability were evaluated. Immunoprofiling and foam cell quantification were performed. Results: Peli1 deficiency does not affect atherosclerosis lesion burden and cholesterol levels, but promotes VSMCs foam cells formation, necrotic core expansion, collagen, and fibrous cap reduction. Apoe−/− Peli1−/− mice exhibit a storm of inflammatory cytokines, expansion of Th1, Th1, Th17, and Tfh cells, a decrease in regulatory T and B cells and induction of pro-atherogenic serum level of IgG2a and IgE. Conclusions: In the present study, we uncover a crucial role for Peli1 in atherosclerosis as an important regulator of inflammation and VSMCs phenotypic modulation and subsequently atherosclerotic plaque destabilization. Atherosclerosis is a chronic inflammatory vascular disease and the main cause of death and morbidity. Emerging evidence suggests that ubiquitination plays an important role in the pathogenesis of atherosclerosis including control of vascular inflammation, vascular smooth muscle cell (VSMC) function and atherosclerotic plaque stability. Peli1 a type of E3 ubiquitin ligase has emerged as a critical regulator of innate and adaptive immunity, however, its role in atherosclerosis remains to be elucidated.BACKGROUNDAtherosclerosis is a chronic inflammatory vascular disease and the main cause of death and morbidity. Emerging evidence suggests that ubiquitination plays an important role in the pathogenesis of atherosclerosis including control of vascular inflammation, vascular smooth muscle cell (VSMC) function and atherosclerotic plaque stability. Peli1 a type of E3 ubiquitin ligase has emerged as a critical regulator of innate and adaptive immunity, however, its role in atherosclerosis remains to be elucidated.Apoe-/- mice and Peli1-deficient Apoe-/- Peli1-/- mice were subject to high cholesterol diet. Post sacrifice, serum was collected, and atherosclerotic plaque size and parameters of atherosclerotic plaque stability were evaluated. Immunoprofiling and foam cell quantification were performed.METHODSApoe-/- mice and Peli1-deficient Apoe-/- Peli1-/- mice were subject to high cholesterol diet. Post sacrifice, serum was collected, and atherosclerotic plaque size and parameters of atherosclerotic plaque stability were evaluated. Immunoprofiling and foam cell quantification were performed.Peli1 deficiency does not affect atherosclerosis lesion burden and cholesterol levels, but promotes VSMCs foam cells formation, necrotic core expansion, collagen, and fibrous cap reduction. Apoe-/- Peli1-/- mice exhibit a storm of inflammatory cytokines, expansion of Th1, Th1, Th17, and Tfh cells, a decrease in regulatory T and B cells and induction of pro-atherogenic serum level of IgG2a and IgE.RESULTSPeli1 deficiency does not affect atherosclerosis lesion burden and cholesterol levels, but promotes VSMCs foam cells formation, necrotic core expansion, collagen, and fibrous cap reduction. Apoe-/- Peli1-/- mice exhibit a storm of inflammatory cytokines, expansion of Th1, Th1, Th17, and Tfh cells, a decrease in regulatory T and B cells and induction of pro-atherogenic serum level of IgG2a and IgE.In the present study, we uncover a crucial role for Peli1 in atherosclerosis as an important regulator of inflammation and VSMCs phenotypic modulation and subsequently atherosclerotic plaque destabilization.CONCLUSIONSIn the present study, we uncover a crucial role for Peli1 in atherosclerosis as an important regulator of inflammation and VSMCs phenotypic modulation and subsequently atherosclerotic plaque destabilization. |
Author | Burger, Fabienne Roth, Aline Brandt, Karim J. Miteva, Kapka Baptista, Daniela |
AuthorAffiliation | Division of Cardiology, Foundation for Medical Research, Department of Medicine Specialized Medicine, Faculty of Medicine, University of Geneva, Av. de la Roseraie 64, CH-1211 Geneva, Switzerland; fabienne.burger@unige.ch (F.B.); daniela.baptista@unige.ch (D.B.); aline.roth@unige.ch (A.R.); karim.brandt@unige.ch (K.J.B.) |
AuthorAffiliation_xml | – name: Division of Cardiology, Foundation for Medical Research, Department of Medicine Specialized Medicine, Faculty of Medicine, University of Geneva, Av. de la Roseraie 64, CH-1211 Geneva, Switzerland; fabienne.burger@unige.ch (F.B.); daniela.baptista@unige.ch (D.B.); aline.roth@unige.ch (A.R.); karim.brandt@unige.ch (K.J.B.) |
Author_xml | – sequence: 1 givenname: Fabienne surname: Burger fullname: Burger, Fabienne – sequence: 2 givenname: Daniela surname: Baptista fullname: Baptista, Daniela – sequence: 3 givenname: Aline surname: Roth fullname: Roth, Aline – sequence: 4 givenname: Karim J. orcidid: 0000-0003-1042-5283 surname: Brandt fullname: Brandt, Karim J. – sequence: 5 givenname: Kapka orcidid: 0000-0002-6722-8400 surname: Miteva fullname: Miteva, Kapka |
BookMark | eNp1kc9rFDEcxYNUbK09eh_w4mVqfk9yEUqttbBiD-05ZJLv7GaZTdpkptD_3oxbxC2YQxLy_eTxeO89OoopAkIfCT5nTOMvDsaxEEIYxYS_QScUd6zlHOujf-7H6KyULa5LEUmweIeOmVBYYC1O0M-7DTRXrLnvw-McphCbVVjbAs0tjIE032AILkB0z81tTrs0QWkupg3kVNy47KEsg3WGUkKKH9DbwY4Fzl7OU3T__eru8ke7-nV9c3mxah0Xamp9b_UA4IEKzhhXXkrnqJa968AqK4WSSjPs5KCEZ4PsBHQEbAeeCWalYqfoZq_rk92ahxx2Nj-bZIP585Dy2tg8hWrRUCGxkt5yRnruwPaUe6prXF4JoZyvWl_3Wg9zvwPvIE7Zjgeih5MYNmadnoymUjBOqsDnF4GcHmcok9mFsjRjI6S5GCpV1xHVia6in16h2zTnWKNaKKG1FoJWqt1TrgZcMgx_zRBslt7NQe-VZ694FyY71T6q3zD-59dv2H2yHg |
CitedBy_id | crossref_primary_10_1038_s41392_023_01439_y crossref_primary_10_1038_s42003_025_07839_w crossref_primary_10_1186_s10020_024_00798_8 crossref_primary_10_3389_fimmu_2023_1292022 crossref_primary_10_1016_j_jep_2024_118125 crossref_primary_10_3389_fcell_2024_1481505 crossref_primary_10_1002_ctm2_1719 crossref_primary_10_1097_FJC_0000000000001441 crossref_primary_10_3390_cells12111527 |
Cites_doi | 10.1161/CIRCRESAHA.108.187302 10.1038/ni.2090 10.1161/ATVBAHA.111.231563 10.1038/nm.3111 10.1093/cvr/cvt097 10.1158/2326-6066.CIR-21-0419 10.1016/j.it.2008.10.001 10.1155/2016/1532832 10.1038/ni.1777 10.3390/cells11030411 10.1016/S0002-9440(10)64820-1 10.1111/j.1582-4934.2007.00040.x 10.1161/01.ATV.14.1.133 10.1016/j.yjmcc.2016.03.013 10.1016/j.thromres.2011.03.025 10.1161/ATVBAHA.114.303567 10.1161/CIRCRESAHA.115.306361 10.5551/jat.3418 10.1160/TH16-02-0139 10.1016/j.jacc.2020.08.011 10.1161/ATVBAHA.119.313744 10.1172/JCI119465 10.1093/cvr/cvy022 10.1111/joim.12406 10.3390/ijms23010340 10.1073/pnas.83.20.7760 10.3389/fimmu.2020.599415 10.1161/ATVBAHA.114.304029 10.1161/CIRCRESAHA.115.307611 10.1161/CIRCULATIONAHA.105.562041 10.1016/j.atherosclerosis.2020.10.102 10.1016/j.heliyon.2020.e03441 10.1161/01.CIR.103.7.926 10.1161/ATVBAHA.117.310678 10.3389/fimmu.2019.02795 10.1016/j.celrep.2021.109904 10.1161/CIRCRESAHA.118.311362 10.1111/j.1540-8183.2002.tb01087.x 10.2174/0929867327666200306124418 10.1161/CIRCRESAHA.118.313591 10.1194/jlr.R800092-JLR200 10.1038/s41573-021-00198-1 10.1161/01.ATV.0000201071.49029.17 10.4061/2011/936109 10.1038/s41467-018-03530-3 |
ContentType | Journal Article |
Copyright | 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022 by the authors. 2022 |
Copyright_xml | – notice: 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022 by the authors. 2022 |
DBID | AAYXX CITATION 8FD 8FE 8FH ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 GNUQQ HCIFZ LK8 M7P P64 PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI PRINS RC3 7X8 5PM DOA |
DOI | 10.3390/cells11132014 |
DatabaseName | CrossRef Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Journals ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Engineering Research Database ProQuest Central Student ProQuest SciTech Premium Collection Biological Sciences Biological Science Database Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef Publicly Available Content Database ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences Genetics Abstracts Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Biological Science Database ProQuest SciTech Collection Biotechnology and BioEngineering Abstracts ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2073-4409 |
ExternalDocumentID | oai_doaj_org_article_256086da431b4ceab24d29014d8558cd PMC9265341 10_3390_cells11132014 |
GeographicLocations | St Louis Missouri United States--US Germany |
GeographicLocations_xml | – name: St Louis Missouri – name: United States--US – name: Germany |
GrantInformation_xml | – fundername: Swiss National Science Foundation Grants grantid: #310030_152912/1 |
GroupedDBID | 53G 5VS 8FE 8FH AADQD AAFWJ AAYXX ABDBF ACUHS ADBBV AFKRA AFPKN AFZYC ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BBNVY BCNDV BENPR BHPHI CCPQU CITATION DIK EBD ESX GROUPED_DOAJ HCIFZ HYE IAO IHR ITC KQ8 LK8 M48 M7P MODMG M~E OK1 PGMZT PHGZM PHGZT PIMPY PROAC RPM 8FD ABUWG AZQEC DWQXO FR3 GNUQQ P64 PKEHL PQEST PQGLB PQQKQ PQUKI PRINS RC3 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c458t-dba9feede2543348d66cc296bc7ea8a65868930c6f85d3f675e71ea7ed353a683 |
IEDL.DBID | M48 |
ISSN | 2073-4409 |
IngestDate | Wed Aug 27 01:30:27 EDT 2025 Thu Aug 21 18:33:59 EDT 2025 Thu Jul 10 22:50:25 EDT 2025 Fri Jul 25 11:46:52 EDT 2025 Tue Jul 01 01:00:35 EDT 2025 Thu Apr 24 22:52:15 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 13 |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c458t-dba9feede2543348d66cc296bc7ea8a65868930c6f85d3f675e71ea7ed353a683 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-6722-8400 0000-0003-1042-5283 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/cells11132014 |
PMID | 35805095 |
PQID | 2685999552 |
PQPubID | 2032536 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_256086da431b4ceab24d29014d8558cd pubmedcentral_primary_oai_pubmedcentral_nih_gov_9265341 proquest_miscellaneous_2687718757 proquest_journals_2685999552 crossref_primary_10_3390_cells11132014 crossref_citationtrail_10_3390_cells11132014 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20220623 |
PublicationDateYYYYMMDD | 2022-06-23 |
PublicationDate_xml | – month: 6 year: 2022 text: 20220623 day: 23 |
PublicationDecade | 2020 |
PublicationPlace | Basel |
PublicationPlace_xml | – name: Basel |
PublicationTitle | Cells (Basel, Switzerland) |
PublicationYear | 2022 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | Furtmair (ref_28) 2020; 315 Zhang (ref_12) 2021; 37 Wolf (ref_1) 2019; 124 Virmani (ref_4) 2002; 15 Xiao (ref_9) 2013; 19 Relvas (ref_32) 2010; 17 Whitman (ref_34) 2000; 157 Hansson (ref_43) 2015; 278 Chang (ref_10) 2011; 12 Zhang (ref_26) 2020; 40 Seneviratne (ref_24) 2013; 99 Quillard (ref_23) 2011; 31 Chang (ref_8) 2009; 10 Soehnlein (ref_44) 2021; 20 ref_19 Talepoor (ref_30) 2020; 8 ref_16 Liu (ref_11) 2018; 9 Montecucco (ref_21) 2016; 116 Carbone (ref_20) 2016; 94 Pamukcu (ref_14) 2011; 128 Herrington (ref_2) 2016; 118 Nakashima (ref_17) 1994; 14 Allahverdian (ref_39) 2018; 114 Quintero (ref_36) 2020; 6 Gupta (ref_33) 1997; 99 Schauvliege (ref_6) 2007; 11 Deguchi (ref_22) 2005; 112 Albany (ref_35) 2019; 10 Frontini (ref_40) 2009; 104 Tay (ref_37) 2018; 38 Segers (ref_46) 2011; 2011 Everett (ref_45) 2020; 76 Bennett (ref_3) 2016; 118 Wolfbauer (ref_38) 1986; 83 Moynagh (ref_7) 2009; 30 Zhou (ref_5) 2021; 28 Vengrenyuk (ref_42) 2015; 35 Roshan (ref_13) 2016; 2016 Park (ref_27) 2022; 10 Crisby (ref_25) 2001; 103 Taleb (ref_29) 2015; 35 Mallat (ref_31) 2009; 50 Grebe (ref_15) 2018; 122 Sorokin (ref_41) 2020; 11 Getz (ref_18) 2006; 26 |
References_xml | – volume: 104 start-page: 832 year: 2009 ident: ref_40 article-title: Lipid Incorporation Inhibits Src-Dependent Assembly of Fibronectin and Type I Collagen by Vascular Smooth Muscle Cells publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.108.187302 – volume: 12 start-page: 1002 year: 2011 ident: ref_10 article-title: The ubiquitin ligase Peli1 negatively regulates T cell activation and prevents autoimmunity publication-title: Nat. Immunol. doi: 10.1038/ni.2090 – volume: 31 start-page: 2464 year: 2011 ident: ref_23 article-title: Selective Inhibition of Matrix Metalloproteinase-13 Increases Collagen Content of Established Mouse Atherosclerosis publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.111.231563 – volume: 19 start-page: 595 year: 2013 ident: ref_9 article-title: Peli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradation publication-title: Nat. Med. doi: 10.1038/nm.3111 – volume: 99 start-page: 284 year: 2013 ident: ref_24 article-title: Biomechanical factors and macrophages in plaque stability publication-title: Cardiovasc. Res. doi: 10.1093/cvr/cvt097 – volume: 10 start-page: 327 year: 2022 ident: ref_27 article-title: The Pellino1-PKCθ Signaling Axis Is an Essential Target for Improving Antitumor CD8+ T-lymphocyte Function publication-title: Cancer Immunol. Res. doi: 10.1158/2326-6066.CIR-21-0419 – volume: 30 start-page: 33 year: 2009 ident: ref_7 article-title: The Pellino family: IRAK E3 ligases with emerging roles in innate immune signalling publication-title: Trends Immunol. doi: 10.1016/j.it.2008.10.001 – volume: 2016 start-page: 1532832 year: 2016 ident: ref_13 article-title: The Role of TLR2, TLR4, and TLR9 in the Pathogenesis of Atherosclerosis publication-title: Int. J. Inflamm. doi: 10.1155/2016/1532832 – volume: 10 start-page: 1089 year: 2009 ident: ref_8 article-title: Peli1 facilitates TRIF-dependent Toll-like receptor signaling and proinflammatory cytokine production publication-title: Nat. Immunol. doi: 10.1038/ni.1777 – ident: ref_19 doi: 10.3390/cells11030411 – volume: 157 start-page: 1819 year: 2000 ident: ref_34 article-title: Exogenous Interferon-gamma Enhances Atherosclerosis in Apolipoprotein E−/− Mice publication-title: Am. J. Pathol. doi: 10.1016/S0002-9440(10)64820-1 – volume: 11 start-page: 453 year: 2007 ident: ref_6 article-title: Pellino Proteins: Novel Players in TLR and IL-1R Signalling publication-title: J. Cell. Mol. Med. doi: 10.1111/j.1582-4934.2007.00040.x – volume: 14 start-page: 133 year: 1994 ident: ref_17 article-title: ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree publication-title: Arterioscler. Thromb. doi: 10.1161/01.ATV.14.1.133 – volume: 94 start-page: 82 year: 2016 ident: ref_20 article-title: Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injury publication-title: J. Mol. Cell. Cardiol. doi: 10.1016/j.yjmcc.2016.03.013 – volume: 128 start-page: 117 year: 2011 ident: ref_14 article-title: The nuclear factor—Kappa B pathway in atherosclerosis: A potential therapeutic target for atherothrombotic vascular disease publication-title: Thromb. Res. doi: 10.1016/j.thromres.2011.03.025 – volume: 35 start-page: 258 year: 2015 ident: ref_29 article-title: IL-17 and Th17 Cells in Atherosclerosis publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.114.303567 – volume: 118 start-page: 692 year: 2016 ident: ref_3 article-title: Vascular Smooth Muscle Cells in Atherosclerosis publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.115.306361 – volume: 17 start-page: 378 year: 2010 ident: ref_32 article-title: Resident peritoneal inflammatory cells are pivotal in the development of experimental atherosclerosis publication-title: J. Arterioscler. Thromb. doi: 10.5551/jat.3418 – volume: 116 start-page: 987 year: 2016 ident: ref_21 article-title: Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesis publication-title: Thromb. Haemost. doi: 10.1160/TH16-02-0139 – volume: 76 start-page: 1660 year: 2020 ident: ref_45 article-title: Inhibition of Interleukin-1β and Reduction in Atherothrombotic Cardiovascular Events in the CANTOS Trial publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2020.08.011 – volume: 40 start-page: 597 year: 2020 ident: ref_26 article-title: IgE Contributes to Atherosclerosis and Obesity by Affecting Macrophage Polarization, Macrophage Protein Network, and Foam Cell Formation publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.119.313744 – volume: 99 start-page: 2752 year: 1997 ident: ref_33 article-title: IFN-gamma potentiates atherosclerosis in ApoE knock-out mice publication-title: J. Clin. Investig. doi: 10.1172/JCI119465 – volume: 114 start-page: 540 year: 2018 ident: ref_39 article-title: Smooth muscle cell fate and plasticity in atherosclerosis publication-title: Cardiovasc. Res. doi: 10.1093/cvr/cvy022 – volume: 278 start-page: 483 year: 2015 ident: ref_43 article-title: Inflammation and plaque vulnerability publication-title: J. Intern. Med. doi: 10.1111/joim.12406 – ident: ref_16 doi: 10.3390/ijms23010340 – volume: 83 start-page: 7760 year: 1986 ident: ref_38 article-title: Development of the smooth muscle foam cell: Uptake of macrophage lipid inclusions publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.83.20.7760 – volume: 11 start-page: 599415 year: 2020 ident: ref_41 article-title: Role of Vascular Smooth Muscle Cell Plasticity and Interactions in Vessel Wall Inflammation publication-title: Front. Immunol. doi: 10.3389/fimmu.2020.599415 – volume: 35 start-page: 535 year: 2015 ident: ref_42 article-title: Cholesterol Loading Reprograms the MicroRNA-143/145–Myocardin Axis to Convert Aortic Smooth Muscle Cells to a Dysfunctional Macrophage-Like Phenotype publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.114.304029 – volume: 118 start-page: 535 year: 2016 ident: ref_2 article-title: Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.115.307611 – volume: 112 start-page: 2708 year: 2005 ident: ref_22 article-title: Matrix Metalloproteinase-13/Collagenase-3 Deletion Promotes Collagen Accumulation and Organization in Mouse Atherosclerotic Plaques publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.105.562041 – volume: 315 start-page: E30 year: 2020 ident: ref_28 article-title: TH1 cytokines as proatherogenic key players of atherosclerotic plaque progression publication-title: Arteriosclerosis doi: 10.1016/j.atherosclerosis.2020.10.102 – volume: 6 start-page: e03441 year: 2020 ident: ref_36 article-title: Low frequency of IL-10(+) B cells in patients with atherosclerosis is related with inflammatory condition publication-title: Heliyon doi: 10.1016/j.heliyon.2020.e03441 – volume: 103 start-page: 926 year: 2001 ident: ref_25 article-title: Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: Implications for plaque stabilization publication-title: Circulation doi: 10.1161/01.CIR.103.7.926 – volume: 38 start-page: e71 year: 2018 ident: ref_37 article-title: Follicular B Cells Promote Atherosclerosis via T Cell–Mediated Differentiation into Plasma Cells and Secreting Pathogenic Immunoglobulin G publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.117.310678 – volume: 8 start-page: e14637 year: 2020 ident: ref_30 article-title: Functional subsets of circulating follicular helper T cells in patients with atherosclerosis publication-title: Physiol. Rep. – volume: 10 start-page: 2795 year: 2019 ident: ref_35 article-title: Getting to the Heart of the Matter: The Role of Regulatory T-Cells (Tregs) in Cardiovascular Disease (CVD) and Atherosclerosis publication-title: Front. Immunol. doi: 10.3389/fimmu.2019.02795 – volume: 37 start-page: 109904 year: 2021 ident: ref_12 article-title: Peli1 facilitates NLRP3 inflammasome activation by mediating ASC ubiquitination publication-title: Cell Rep. doi: 10.1016/j.celrep.2021.109904 – volume: 122 start-page: 1722 year: 2018 ident: ref_15 article-title: NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.118.311362 – volume: 15 start-page: 439 year: 2002 ident: ref_4 article-title: Vulnerable Plaque: The Pathology of Unstable Coronary Lesions publication-title: J. Interv. Cardiol. doi: 10.1111/j.1540-8183.2002.tb01087.x – volume: 28 start-page: 152 year: 2021 ident: ref_5 article-title: The Role of Ubiquitin E3 Ligase in Atherosclerosis publication-title: Curr. Med. Chem. doi: 10.2174/0929867327666200306124418 – volume: 124 start-page: 315 year: 2019 ident: ref_1 article-title: Immunity and Inflammation in Atherosclerosis publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.118.313591 – volume: 50 start-page: S364 year: 2009 ident: ref_31 article-title: The role of adaptive T cell immunity in atherosclerosis publication-title: J. Lipid Res. doi: 10.1194/jlr.R800092-JLR200 – volume: 20 start-page: 589 year: 2021 ident: ref_44 article-title: Targeting inflammation in atherosclerosis—From experimental insights to the clinic publication-title: Nat. Rev. Drug Discov. doi: 10.1038/s41573-021-00198-1 – volume: 26 start-page: 242 year: 2006 ident: ref_18 article-title: Diet and Murine Atherosclerosis publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/01.ATV.0000201071.49029.17 – volume: 2011 start-page: 936109 year: 2011 ident: ref_46 article-title: Atherosclerotic Plaque Stability Is Affected by the Chemokine CXCL10 in Both Mice and Humans publication-title: Int. J. Inflamm. doi: 10.4061/2011/936109 – volume: 9 start-page: 1136 year: 2018 ident: ref_11 article-title: Peli1 negatively regulates noncanonical NF-κB signaling to restrain systemic lupus erythematosus publication-title: Nat. Commun. doi: 10.1038/s41467-018-03530-3 |
SSID | ssj0000816105 |
Score | 2.2533073 |
Snippet | Background: Atherosclerosis is a chronic inflammatory vascular disease and the main cause of death and morbidity. Emerging evidence suggests that... Atherosclerosis is a chronic inflammatory vascular disease and the main cause of death and morbidity. Emerging evidence suggests that ubiquitination plays an... |
SourceID | doaj pubmedcentral proquest crossref |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
StartPage | 2014 |
SubjectTerms | Abdomen Adaptive immunity Apolipoprotein E Arteriosclerosis Atherosclerosis Cholesterol Cloning Collagen Coronary vessels Cytokines Flow cytometry foam cells Helper cells High cholesterol diet High density lipoprotein Immunoglobulin E Immunoglobulin G Inflammation Laboratory animals Lymphocytes B Lymphocytes T Morbidity Pathogenesis plaque stability Smooth muscle T cell receptors Ubiquitin ubiquitin ligase Ubiquitin-protein ligase Ubiquitination Vascular diseases VSMCs |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8NAEF6kIHgRnxitsoJ4MjTNPnusWhFR8WCht7DJbmqgpGrag__emU0szUG8eMkhO2STmex-3yTzIOTCRDbnIs_DyLgsBP7PQg3EIhQ651YD4qoIs5GfnuX9mD9MxGSt1RfGhNXlgWvF9RCStbQGgC7lmTNpzK3_92e1EDqzuPsC5q05U34PxgkjURfVZODX9_A7eOX7qkd93gIhX6u_RTDb4ZFreHO3Q7YbokiH9Q3ukg1X7pHNunXk1z55AvvSEaPjtPhYFouipI_FFBCJvrhZ0ae3DitDYFolffEBd66iQ-R68wquBseiwoFpHQVbHpDx3ej15j5sWiOEGRd6EdrUDHKAN4e57IxrKzH-eSDTTDmjDdAKCUQkymSuhWU5eAVO9Z1RzjLBjNTskHTKeemOCO0raXIEelAoV3FqDDAm5iLtmLbcmoBc_egqyZq64di-YpaA_4CqTVqqDcjlSvy9Lpjxm-A1Kn4lhHWu_QmwftJYP_nL-gHp_pgtaRZflcRSC-C9QsQBOV8Nw7LB-U3p5ksvowCWlVABUS1zt26oPVIWb74A9yCWAtD_-D-e4IRsxZhREckwZl3SWXwu3SnwnEV65l_pb8z0_JY priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEB9qi-CLaFWM1rJC8cmlueznPUlrrxRpy1F60LewyW7OQEna5u7B_96ZZO80D_qSh-yQDTO7O7-ZnQ-AI5f6Sqqq4qkLJUf8L7hFYMGVraS3qHFNStnIV9f6YiF_3Km76HDrYljl5kzsD2rfluQjP860VQhmlMq-PTxy6hpFt6uxhcYz2MMj2KLxtXc6u57fbL0s1FYCEcRQXFOgfX9M_vCu76-eTuRIGfU1-0dAcxwm-ZfeOX8FLyNgZCeDhF_DTmj24fnQQvLXG7hCObOZYIuiflzXq7phl_USNRObh_t6ws4CVYig9Eo27wPvQsdOCPO1HX4Nn3VHA8shGrZ5C4vz2e33Cx5bJPBSKrvivnDTCtVcoJx2Ia3XFAc91UVpgrMO4YVGQJKWurLKiwqtg2AmwZnghRJOW_EOdpu2Ce-BTYx2FSl8b5U0WeEcIicRUhuE9dK7BL5ueJWXsX44tbG4z9GOINbmI9Ym8GVL_jAUzvgX4SkxfktE9a77F-3TMo_bJydgZrV3CHcKWQZXZNL3N8D4s8qWPoGDjdjyuAm7_M-SSeDzdhi3D83vmtCuexqD6tkok4AZiXv0Q-ORpv7ZF-KeZlohCvjw_8k_wouMciZSzTNxALurp3X4hEhmVRzG5fobjsD1-w priority: 102 providerName: ProQuest |
Title | The E3 Ubiquitin Ligase Peli1 Deficiency Promotes Atherosclerosis Progression |
URI | https://www.proquest.com/docview/2685999552 https://www.proquest.com/docview/2687718757 https://pubmed.ncbi.nlm.nih.gov/PMC9265341 https://doaj.org/article/256086da431b4ceab24d29014d8558cd |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEB5KQksuoU-qJDVbKD1Vrax9-lBK0jiEUgdTashNrLQrV2DkxrIh-fedWcluRdNLLzpoR9Iys6P5ZnceAG9s4kohyzJOrC9ixP88NggsYmlK4QxaXJ1QNvLkSl3OxJdref27pFDHwOZe1476Sc1Wi_e3N3efUOE_kseJLvsH2uJuQsv0hFpa76NR0qSjkw7ph58yzSCRbZXNv586gEd0HojWU_YMVKjj3wOf_dDJP2zRxWM47EAkO22l_gQe-PopPGzbSt49gwnKno05m-XVzaZaVzX7Ws3RWrGpX1RDdu6pagSlXLJpCMbzDTslHLhs8G14rRoamLcRsvVzmF2Mv3--jLu2CXEhpFnHLrejEk2fpzx3LoxTFBs9UnmhvTUWIYdCkJIUqjTS8RI9Bq-H3mrvuORWGf4C9upl7V8CG2plSwIBzkih09xaRFPcJ8Zz44SzEbzb8iorupri1NpikaFvQVzOelyO4O2O_GdbTONfhGfE-B0R1cAON5aredapVEZgzShnEQLlovA2T4ULp8I4WWkKF8HJVmzZdl1lqTISMbGUaQSvd8OoUvR9W_vlJtBoNNla6gh0T9y9CfVH6upHKM49SpVEZHD0308ew0FKKRaJilN-Anvr1ca_QuCzzgewfza-mn4bhI2DQVjgvwAAPwdg |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrRBcEE8RKGAk4ETUbPyI94BQS7fa0t3VCnWl3oITO0ukKmmbXaH-KX4jM3ks5AC3XnKIR7Y1nvF8tucB8M4ENhMyy_zAuNRH_M99jcDClzoTVqPFjQKKRp7N1WQpvp7L8x341cXCkFtltyfWG7UtU7oj3w-VlghmpAw_X175VDWKXle7EhqNWJy6m594ZKs-nRzh-r4Pw-Px2ZeJ31YV8FMh9dq3iRllaBkchYFzoa0i1-GRStLIGW3QIiu04UGqMi0tzxBQu2joTOQsl9wozbHfO7ArOB5lBrB7OJ4vvm1vdaiMBSKWJpkn56Ngn-7fq7qeezAUPeNX1wjoAdu-W-Zfdu74ITxoASo7aCTqEey44jHcbUpW3jyBGcoVG3O2TPKrTb7OCzbNV2gJ2cJd5EN25CgjBYVzskXt6OcqdkAYs6ywN_zmFTWsGu_b4iksb4V5z2BQlIV7DmwYKZMRwLBaiihMjEGkxl2gHddWWOPBx45XcdrmK6eyGRcxnluItXGPtR582JJfNok6_kV4SIzfElF-7fpHeb2KW3WNCQhqZQ3Cq0SkziShsPWLM05W6tR6sNctW9wqfRX_EVEP3m6bUV1pfFO4clPTRAgHIhl5EPWWuzehfkuR_6gTf49CJRF1vPj_4G_g3uRsNo2nJ_PTl3A_pHiNQPkh34PB-nrjXiGKWievW9Fl8P22teU30O0zxw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrUBcEE81UMBIwIlos3H82ANCLburlrarFWKl3oITO0ukKmmbXaH-NX4dM3ks5AC3XnKIR7Y1nvF8tucB8NYENotElvmBcamP-J_7GoGFL3QWWY0WVwUUjXw2l0fL6Mu5ON-BX10sDLlVdntivVHbMqU78mEotUAwI0Q4zFq3iMVk9unyyqcKUvTS2pXTaETkxN38xONb9fF4gmv9Lgxn02-fj_y2woCfRkKvfZuYcYZWwlFIOI-0leRGPJZJqpzRBq2zRHsepDLTwvIMwbVTI2eUs1xwIzXHfu_ArsJTUTCA3cPpfPF1e8NDJS0QvTSJPTkfB0O6i6_q2u7BKOoZwrpeQA_k9l00_7J5s4fwoAWr7KCRrkew44rHcLcpX3nzBM5QxtiUs2WSX23ydV6w03yFVpEt3EU-YhNH2SkotJMtaqc_V7EDwptlhb3hN6-oYdV44hZPYXkrzHsGg6Is3B6wkZImI7BhtYhUmBiDqI27QDuubWSNBx86XsVpm7ucSmhcxHiGIdbGPdZ68H5Lftkk7fgX4SExfktEubbrH-X1Km5VNyZQqKU1CLWSKHUmCSNbvz7jZIVOrQf73bLF7QZQxX_E1YM322ZUXRrfFK7c1DQKoYESygPVW-7ehPotRf6jTgI-DqVABPL8_4O_hnuoJfHp8fzkBdwPKXQjkH7I92Gwvt64lwio1smrVnIZfL9tZfkN0Kk3_A |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+E3+Ubiquitin+Ligase+Peli1+Deficiency+Promotes+Atherosclerosis+Progression&rft.jtitle=Cells+%28Basel%2C+Switzerland%29&rft.au=Burger%2C+Fabienne&rft.au=Baptista%2C+Daniela&rft.au=Roth%2C+Aline&rft.au=Brandt%2C+Karim+J.&rft.date=2022-06-23&rft.pub=MDPI&rft.eissn=2073-4409&rft.volume=11&rft.issue=13&rft_id=info:doi/10.3390%2Fcells11132014&rft_id=info%3Apmid%2F35805095&rft.externalDocID=PMC9265341 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2073-4409&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2073-4409&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2073-4409&client=summon |